A Retrospective, Single-Arm, Observational Study in Patients with Multiple Sclerosis in India Receiving Ocrelizumab Therapy for 1 Year.

Padma Srivastava MV, Mukherji J D, Rohatgi A, Arora S

Ann Indian Acad Neurol. 2026 Aug 19. PMID: 42619664. Abstract